Get a comprehensive report summary describing the market size and forecast along with research methodology. The sample report is available in PDF format
Porter's Five Forces Analysis
The threat of substitutes is high. This is because customers prefer alternatives, such as facial creams, acupuncture, face patches, vitamins, and face exercises, due to their low cost. Hence, the threat of substitutes is expected to remain high during the forecast period.
The Report offers information on all the Porter's Five Forces. Buy Now to gain insights that will help you improve your business.
Vendor Landscape
The facial aesthetics market is becoming highly competitive. This is attributed to factors such as the presence of region-specific vendors operating in the market. In addition, the market is witnessing consolidation, as major players are acquiring smaller vendors. Some of the key vendors operating in the market include AbbVie Inc., Adoderm GmbH, Alma Lasers GmbH, Anika Therapeutics Inc., Bausch Health Companies Inc., and Contura Ltd.
The report provides a full list of key vendors, their strategies, and the latest developments. Request a PDF Sample Now
Market Segmentation
The facial aesthetics market has been segmented by product into botulinum toxin, dermal fillers, and others. Among these, botulinum toxin will account for the highest market growth. These advertisements have a stronger audio-visual effect, which gives viewers a positive product impression. It is an effective non-surgical anti-wrinkle procedure, which is increasing its demand. Botulinum toxin is used for treating chronic wrinkles on the forehead, eyelids, and lips.
By geography, the market has been segmented into North America, Europe, APAC, South America, and the Middle East and Africa. North America will have the highest market growth during the forecast period. The US and Canada are the key countries in the region. According to the centers for Disease Control and Prevention (CDC), the elderly population of the US will account for roughly 20% of the total population. Many people from this group opt for facial aesthetic products to remove wrinkles.
Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a PDF Sample Report
Key Drivers and Trends
The increase in cosmetic treatment among consumers is driving the facial aesthetics market growth. The adoption of facial aesthetics products is high in countries such as Brazil, the US, and Venezuela owing to high awareness, a rise in the marketing of these procedures, and increased media coverage. The demand for these procedures is high due to their non-invasive nature and faster recovery period.
The growing demand for facial aesthetics from men is a key trend in the market. Men are also showing interest in certain cosmetic procedures such as botulinum toxin, dermal fillers, chemical peel, and microdermabrasion. The perception among men regarding the importance of these procedures is changing, which is supporting the market growth.
Apart from the growing demand for facial aesthetics from men, many other trends are also shaping the future of the market. View PDF Sample Report to learn about these trends
Similar Reports
Bone Grafts and Substitutes Market by Type and Geography - Forecast and Analysis 2022-2026
Breast Cancer Liquid Biopsy Market by Product Type and Geography - Forecast and Analysis 2022-2026
Facial Aesthetics Market Scope |
Report Coverage |
Details |
Page number |
120 |
Base year |
2020 |
Forecast period |
2021-2025 |
Growth momentum & CAGR |
Accelerate at a CAGR of 4.45% |
Market growth 2021-2025 |
USD 1.45 billion |
Market structure |
Fragmented |
YoY growth (%) |
3.14 |
Regional analysis |
North America, Europe, Asia, and ROW |
Performing market contribution |
North America at 41% |
Key consumer countries |
US, Germany, China, France, and Canada |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
AbbVie Inc., Adoderm GmbH, Alma Lasers GmbH, Anika Therapeutics Inc., Bausch Health Companies Inc., Contura Ltd., Galderma SA, Ipsen Pharma SA, Merz Pharma GmbH & Co. KGaA, and Teoxane SA |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Table of Contents
1 Executive Summary
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 01: Parent market
- Exhibit 02: Market characteristics
- 2.2 Value chain analysis
- Exhibit 03: Value chain analysis for life sciences tools and services
3 Market Sizing
- 3.1 Market definition
- Exhibit 04: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 05: Market segments
- 3.4 Market outlook: Forecast for 2020 - 2025
- Exhibit 06: Global - Market size and forecast 2020 - 2025 ($ million)
- Exhibit 07: Global market: Year-over-year growth 2020 - 2025 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 08: Five forces analysis 2020 & 2025
- 4.2 Bargaining power of buyers
- Exhibit 09: Bargaining power of buyers
- 4.3 Bargaining power of suppliers
- Exhibit 10: Bargaining power of suppliers
- 4.4 Threat of new entrants
- Exhibit 11: Threat of new entrants
- 4.5 Threat of substitutes
- Exhibit 12: Threat of substitutes
- 4.6 Threat of rivalry
- Exhibit 13: Threat of rivalry
- 4.7 Market condition
- Exhibit 14: Market condition - Five forces 2020
5 Market Segmentation by Product
- 5.1 Market segments
- Exhibit 15: Product - Market share 2020-2025 (%)
- 5.2 Comparison by Product
- Exhibit 16: Comparison by Product
- 5.3 Botulinum toxin - Market size and forecast 2020-2025
- Exhibit 17: Botulinum toxin - Market size and forecast 2020-2025 ($ million)
- Exhibit 18: Botulinum toxin - Year-over-year growth 2020-2025 (%)
- 5.4 Dermal fillers - Market size and forecast 2020-2025
- Exhibit 19: Dermal fillers - Market size and forecast 2020-2025 ($ million)
- Exhibit 20: Dermal fillers - Year-over-year growth 2020-2025 (%)
- 5.5 Others - Market size and forecast 2020-2025
- Exhibit 21: Others - Market size and forecast 2020-2025 ($ million)
- Exhibit 22: Others - Year-over-year growth 2020-2025 (%)
- 5.6 Market opportunity by Product
- Exhibit 23: Market opportunity by Product
6 Customer landscape
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 25: Market share by geography 2020-2025 (%)
- 7.2 Geographic comparison
- Exhibit 26: Geographic comparison
- 7.3 North America - Market size and forecast 2020-2025
- Exhibit 27: North America - Market size and forecast 2020-2025 ($ million)
- Exhibit 28: North America - Year-over-year growth 2020-2025 (%)
- 7.4 Europe - Market size and forecast 2020-2025
- Exhibit 29: Europe - Market size and forecast 2020-2025 ($ million)
- Exhibit 30: Europe - Year-over-year growth 2020-2025 (%)
- 7.5 Asia - Market size and forecast 2020-2025
- Exhibit 31: Asia - Market size and forecast 2020-2025 ($ million)
- Exhibit 32: Asia - Year-over-year growth 2020-2025 (%)
- 7.6 ROW - Market size and forecast 2020-2025
- Exhibit 33: ROW - Market size and forecast 2020-2025 ($ million)
- Exhibit 34: ROW - Year-over-year growth 2020-2025 (%)
- 7.7 Key leading countries
- Exhibit 35: Key leading countries
- 7.8 Market opportunity by geography
- Exhibit 36: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
- 8.2 Market challenges
- Exhibit 37: Impact of drivers and challenges
9 Vendor Landscape
- 9.2 Vendor landscape
- Exhibit 38: Vendor landscape
- 9.3 Landscape disruption
- Exhibit 39: Landscape disruption
- Exhibit 40: Industry risks
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 41: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 42: Market positioning of vendors
- 10.3 AbbVie Inc.
- Exhibit 43: AbbVie Inc. - Overview
- Exhibit 44: AbbVie Inc. - Product and service
- Exhibit 45: AbbVie Inc. – Key news
- Exhibit 46: AbbVie Inc. - Key offerings
- 10.4 Adoderm GmbH
- Exhibit 47: Adoderm GmbH - Overview
- Exhibit 48: Adoderm GmbH - Product and service
- Exhibit 49: Adoderm GmbH - Key offerings
- 10.6 Anika Therapeutics Inc.
- Exhibit 54: Anika Therapeutics Inc. - Overview
- Exhibit 55: Anika Therapeutics Inc. - Business segments
- Exhibit 56: Anika Therapeutics Inc. – Key news
- Exhibit 57: Anika Therapeutics Inc. - Key offerings
- 10.7 Bausch Health Companies Inc.
- Exhibit 58: Bausch Health Companies Inc. - Overview
- Exhibit 59: Bausch Health Companies Inc. - Business segments
- Exhibit 60: Bausch Health Companies Inc. – Key news
- Exhibit 61: Bausch Health Companies Inc. - Key offerings
- Exhibit 62: Bausch Health Companies Inc. - Segment focus
- 10.8 Contura Ltd.
- Exhibit 63: Contura Ltd. - Overview
- Exhibit 64: Contura Ltd. - Product and service
- Exhibit 65: Contura Ltd. – Key news
- Exhibit 66: Contura Ltd. - Key offerings
- 10.9 Galderma SA
- Exhibit 67: Galderma SA - Overview
- Exhibit 68: Galderma SA - Product and service
- Exhibit 69: Galderma SA – Key news
- Exhibit 70: Galderma SA - Key offerings
- 10.10 Ipsen Pharma SA
- Exhibit 71: Ipsen Pharma SA - Overview
- Exhibit 72: Ipsen Pharma SA - Business segments
- Exhibit 73: Ipsen Pharma SA – Key news
- Exhibit 74: Ipsen Pharma SA - Key offerings
- Exhibit 75: Ipsen Pharma SA - Segment focus
- 10.11 Merz Pharma GmbH & Co. KGaA
- Exhibit 76: Merz Pharma GmbH & Co. KGaA - Overview
- Exhibit 77: Merz Pharma GmbH & Co. KGaA - Product and service
- Exhibit 78: Merz Pharma GmbH & Co. KGaA – Key news
- Exhibit 79: Merz Pharma GmbH & Co. KGaA - Key offerings
- 10.12 Teoxane SA
- Exhibit 80: Teoxane SA - Overview
- Exhibit 81: Teoxane SA - Product and service
- Exhibit 82: Teoxane SA - Key offerings
11 Appendix
- 11.2 Currency conversion rates for US$
- Exhibit 83: Currency conversion rates for US$
- 11.3 Research methodology
- Exhibit 84: Research Methodology
- Exhibit 85: Validation techniques employed for market sizing
- Exhibit 86: Information sources
- 11.4 List of abbreviations
- Exhibit 87: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article